Schott North America INC and Affiliate (Formerly Schott North America INC)
manufacturing
Based in NY
🤖
AI Overview
With $2.8M in lobbying spend across 25 quarterly filings, Schott North America INC and Affiliate (Formerly Schott North America INC) is a significant lobbying presence. They deploy 15 individual lobbyists Their lobbying covers 4 issue areas. Active from 2020 to 2025.
$2.8M
Total Spend
6
Years Active
1
Firms Hired
15
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $330K |
| 2021 | $950K |
| 2022 | $400K |
| 2023 | $490K |
| 2024 | $280K |
| 2025 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Science/Technology, Health Issues, Defense, Tariffs
- •issues relating to grant funding
- •issues relating to funding opportunities through HHS and Operation Warp Speed
Related Analysis
📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders
🏭 Pharma Lobbying
Industry overview and top spenders
🏭 Defense Lobbying
Industry overview and top spenders
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.